Funding Round
Neuralace Medical raises $24M Series B for closed-loop cortical pain stimulation
Business Wire2/21/2026·02/21/26🌐 USA
Summary
Seattle-based Neuralace Medical secured $24M Series B led by Merck Global Health Innovation, with Ascension Ventures and Ally Bridge Group. The Aidaptus epidural cortical stimulation system uses closed-loop feedback to deliver adaptive stimulation for chronic pain conditions refractory to spinal cord stimulation. FDA Breakthrough Device designated.
Why it matters
Cortical stimulation for pain is a frontier indication with potential for patients who have failed all other neuromodulation options. Breakthrough Device designation and Merck GHI investment suggest the FDA pathway is well-defined and the technology has serious corporate validation.
#Neurostimulation#Chronic Pain#Closed-Loop#USA
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trialAlready a member? Sign in